Cargando…
Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037]
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577480/ https://www.ncbi.nlm.nih.gov/pubmed/34454869 http://dx.doi.org/10.1016/j.redox.2021.102117 |
| _version_ | 1784596067521658880 |
|---|---|
| author | Deus, Cláudia M. Pereira, Susana P. Cunha-Oliveira, Teresa Teixeira, José Simões, Rui F. Cagide, Fernando Benfeito, Sofia Borges, Fernanda Raimundo, Nuno Oliveira, Paulo J. |
| author_facet | Deus, Cláudia M. Pereira, Susana P. Cunha-Oliveira, Teresa Teixeira, José Simões, Rui F. Cagide, Fernando Benfeito, Sofia Borges, Fernanda Raimundo, Nuno Oliveira, Paulo J. |
| author_sort | Deus, Cláudia M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8577480 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85774802021-11-15 Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] Deus, Cláudia M. Pereira, Susana P. Cunha-Oliveira, Teresa Teixeira, José Simões, Rui F. Cagide, Fernando Benfeito, Sofia Borges, Fernanda Raimundo, Nuno Oliveira, Paulo J. Redox Biol Corrigendum Elsevier 2021-08-26 /pmc/articles/PMC8577480/ /pubmed/34454869 http://dx.doi.org/10.1016/j.redox.2021.102117 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Corrigendum Deus, Cláudia M. Pereira, Susana P. Cunha-Oliveira, Teresa Teixeira, José Simões, Rui F. Cagide, Fernando Benfeito, Sofia Borges, Fernanda Raimundo, Nuno Oliveira, Paulo J. Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] |
| title | Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] |
| title_full | Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] |
| title_fullStr | Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] |
| title_full_unstemmed | Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] |
| title_short | Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] |
| title_sort | corrigendum to ‘a mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic parkinson's disease patients’. [redox biology 45 (2021) 102037] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577480/ https://www.ncbi.nlm.nih.gov/pubmed/34454869 http://dx.doi.org/10.1016/j.redox.2021.102117 |
| work_keys_str_mv | AT deusclaudiam corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT pereirasusanap corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT cunhaoliveirateresa corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT teixeirajose corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT simoesruif corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT cagidefernando corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT benfeitosofia corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT borgesfernanda corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT raimundonuno corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 AT oliveirapauloj corrigendumtoamitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatientsredoxbiology452021102037 |